Pharmacotherapy (Record no. 41006)

000 -LEADER
fixed length control field 08857nam a2200265 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20190729172934.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 190729b xxu||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781259587481
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1259587487
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name DiPiro, Joseph T.
Relator term ath
245 10 - TITLE STATEMENT
Title Pharmacotherapy
Remainder of title A Pathophysiologic Approach, 10e
246 30 - VARYING FORM OF TITLE
Title proper/short title Pharmacotherapy, A Pathophysiologic Approach, Tenth edition
250 ## - EDITION STATEMENT
Edition statement 10th ed
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. New York, N.Y.
Name of publisher, distributor, etc. McGraw-Hill Education LLC.
Date of publication, distribution, etc. [2017]
490 1# - SERIES STATEMENT
Series statement McGraw-Hill's AccessPharmacy
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and indexes
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note Section 1: Foundation Issues -- Chapter e1: Health
Literacy and Medication Use -- Chapter e2: Cultural
Competency -- Chapter e3: Medication Safety Principles and
Practices -- Chapter e4: Clinical Pharmacokinetics and
Pharmacodynamics -- Chapter e5: Pharmacogenetics --
Chapter e6: Pediatrics -- Chapter e7: Geriatrics --
Chapter e8: Palliative Care -- Chapter e9: Clinical
Toxicology -- Chapter e10: Clinical Management of
Potential Bioterrorism-related Conditions -- Section 2:
Cardiovascular Disorders -- Chapter e11: Cardiovascular
Testing -- Chapter 12: Cardiac Arrest -- Chapter 13:
Hypertension -- Chapter 14: Chronic Heart Failure --
Chapter 15: Acute Decompensated Heart Failure -- Chapter
16: Stable Ischemic Heart Disease -- Chapter 17: Acute
Coronary Syndromes -- Chapter 18: The Arrhythmias --
Chapter 19: Venous Thromboembolism -- Chapter 20: Stroke -
- Chapter 21: Dyslipidemia -- Chapter e22: Peripheral
Arterial Disease -- Chapter 23: Use of Vasopressors and
Inotropes in the Pharmacotherapy of Shock -- Chapter 24:
Hypovolemic Shock -- Chapter e25: Introduction to
Pulmonary Function Testing -- Section 3: Respiratory
Disorders -- Chapter 26: Asthma -- Chapter 27: Chronic
Obstructive Pulmonary Disease -- Chapter 28: Pulmonary
Arterial Hypertension -- Chapter 29: Cystic Fibrosis --
Chapter e30: Drug-Induced Pulmonary Diseases -- Section 4:
Gastrointestinal Disorders -- Chapter e31: Evaluation of
the Gastrointestinal Tract -- Chapter 32: Gastroesophageal
Reflux Disease -- Chapter 33: Peptic Ulcer Disease and
Related Disorders -- Chapter 34: Inflammatory Bowel
Disease -- Chapter 35: Nausea and Vomiting -- Chapter 36:
Diarrhea, Constipation, and Irritable Bowel Syndrome --
Chapter 37: Portal Hypertension and Cirrhosis -- Chapter
e38: Drug-Induced Liver Disease -- Chapter 39:
Pancreatitis -- Chapter 40: Viral Hepatitis -- Chapter 41:
Celiac Disease -- Section 5: Renal Disorders -- Chapter
e42: Evaluation of Kidney Function -- Chapter 43: Acute
Kidney Injury -- Chapter 44: Chronic Kidney Disease --
Chapter 45: Hemodialysis and Peritoneal Dialysis --
Chapter 46: Drug-Induced Kidney Disease -- Chapter 47:
Glomerulonephritis -- Chapter 48: Drug Therapy
Individualization for Patients with Chronic Kidney Disease
-- Chapter 49: Disorders of Sodium and Water Homeostasis -
- Chapter 50: Disorders of Calcium and Phosphorus
Homeostasis -- Chapter 51: Disorders of Potassium and
Magnesium Homeostasis -- Chapter 52: Acid-Base Disorders -
- Section 6: Neurologic Disorders -- Chapter e53:
Evaluation of Neurologic Illness -- Chapter 54: Alzheimer
Disease -- Chapter 55: Multiple Sclerosis -- Chapter 56:
Epilepsy -- Chapter 57: Status Epilepticus -- Chapter 58:
Acute Management of the Brain Injury Patient -- Chapter 59
: Parkinson Disease -- Chapter 60: Pain Management --
Chapter 61: Headache Disorders -- Section 7: Psychiatric
Disorders -- Chapter e62: Assessment of Psychiatric
Disorders -- Chapter 63: Attention Deficit/Hyperactivity
Disorder -- Chapter 64: Eating Disorders -- Chapter 65:
Substance-Related Disorders I: Overview and Depressants,
Stimulants, and Hallucinogens -- Chapter 66: Substance-
Related Disorders II: Alcohol, Nicotine, and Caffeine --
Chapter 67: Schizophrenia -- Chapter 68: Major Depressive
Disorder -- Chapter 69: Bipolar Disorder -- Chapter 70:
Anxiety Disorders: Generalized Anxiety, Panic, and Social
Anxiety Disorders
505 0 Chapter 71: Posttraumatic Stress Disorder and Obsessive-
Compulsive Disorder -- Chapter 72: Sleep-Wake Disorders --
Chapter 73: Disorders Associated with Intellectual
Disabilities -- Section 8: Endocrinologic Disorders --
Chapter 74: Diabetes Mellitus -- Chapter 75: Thyroid
Disorders -- Chapter 76: Adrenal Gland Disorders --
Chapter e77: Pituitary Gland Disorders -- Section 9:
Gynecologic and Obstetric Disorders -- Chapter 78:
Pregnancy and Lactation: Therapeutic Considerations --
Chapter 79: Contraception -- Chapter 80: Menstruation-
Related Disorders -- Chapter 81: Endometriosis -- Chapter
82: Hormone Therapy in Women -- Section 10: Urologic
Disorders -- Chapter 83: Erectile Dysfunction -- Chapter
84: Benign Prostatic Hyperplasia -- Chapter 85: Urinary
Incontinence -- Section 11: Immunologic Disorders --
Chapter e86: Function and Evaluation of the Immune System
-- Chapter 87: Systemic Lupus Erythematosus -- Chapter e88
: Drug Allergy -- Chapter 89: Solid-Organ Transplantation
-- Section 12: Rheumatologic Disorders -- Chapter 90:
Osteoarthritis -- Chapter 91: Rheumatoid Arthritis --
Chapter 92: Osteoporosis and Osteomalacia -- Chapter 93:
Gout and Hyperuricemia -- Section 13: Ophthalmic and
Otolaryngological Disorders -- Chapter 94: Glaucoma --
Chapter 95: Allergic Rhinitis -- Section 14: Dermatologic
Disorders -- Chapter 96: Acne Vulgaris -- Chapter 97:
Psoriasis -- Chapter 98: Atopic Dermatitis -- Chapter e99:
Dermatologic Drug Reactions and Common Skin Conditions --
Section 15: Hematologic Disorders -- Chapter 100: Anemias
-- Chapter 101: Coagulation Disorders -- Chapter 102:
Sickle Cell Disease -- Chapter e103: Drug-Induced
Hematologic Disorders -- Section 16: Infectious Diseases -
- Chapter e104: Laboratory Tests to Direct Antimicrobial
Pharmacotherapy -- Chapter 105: Antimicrobial Regimen
Selection -- Chapter 106: Central Nervous System
Infections -- Chapter 107: Lower Respiratory Tract
Infections -- Chapter 108: Upper Respiratory Tract
Infections -- Chapter 109: Influenza -- Chapter 110: Skin
and Soft-Tissue Infections -- Chapter 111: Infective
Endocarditis -- Chapter 112: Tuberculosis -- Chapter 113:
Gastrointestinal Infections and Enterotoxigenic Poisonings
-- Chapter 114: Intra-Abdominal Infections -- Chapter 116:
Urinary Tract Infections and Prostatitis -- Chapter e115:
Parasitic Diseases -- Chapter 117: Sexually Transmitted
Diseases -- Chapter 118: Bone and Joint Infections --
Chapter 119: Sepsis and Septic Shock -- Chapter 120:
Superficial Fungal Infections -- Chapter 121: Invasive
Fungal Infections -- Chapter 122: Infections in
Immunocompromised Patients -- Chapter 123: Antimicrobial
Prophylaxis in Surgery -- Chapter e124: Travel Health --
Chapter 125: Vaccines and Immunoglobulins -- Chapter 126:
Human Immunodeficiency Virus Infection -- Section 17:
Oncologic Disorders -- Chapter 127: Cancer Treatment and
Chemotherapy -- Chapter 128: Breast Cancer -- Chapter 129:
Lung Cancer -- Chapter 130: Colorectal Cancer -- Chapter
131: Prostate Cancer -- Chapter 132: Lymphomas -- Chapter
133: Ovarian Cancer -- Chapter 134: Acute Leukemias --
Chapter 135: Chronic Leukemias -- Chapter 136: Multiple
Myeloma -- Chapter e137: Myelodysplastic Syndromes --
Chapter e138: Renal Cell Carcinoma -- Chapter 139:
Melanoma -- Chapter 140: Hematopoietic Stem Cell
Transplantation -- Section 18: Nutritional Disorders --
Chapter 141: Assessment of Nutrition Status and Nutrition
Requirements -- Chapter 142: Parenteral Nutrition --
Chapter 143: Enteral Nutrition -- Chapter 144: Obesity
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Source of heading or term Chemotherapy
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Source of heading or term Physiology, Pathological
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Source of heading or term Drug Therapy
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element McGraw-Hill Medical (Firm)
830 #1 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title McGraw-Hill's AccessPharmacy
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Koha item type Books
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Permanent Location Current Location Shelving location Date acquired Full call number Barcode Date last seen Bill Date Koha item type
          WHO HQ WHO HQ BORROWABLE-COLL-STACKS 2019-07-29 WB 330 2017DI 00060026 2019-07-29 2019-07-29 Books